Superiority of twice daily vs once daily oral methylprednisolone in combination with ondansetron in the prevention of delayed emesis due to moderately and highly emetogenic chemotherapy(2002), pp. 2536-2536. ( 38th Annual Meeting of the American Society of Clinical Oncology abs 2831 Orlando ).
Superiority of twice daily vs once daily oral methylprednisolone in combination with ondansetron in the prevention of delayed emesis due to moderately and highly emetogenic chemotherapy
BARBONE, Fabio;
2002-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
